Double Blind Study of TCV-116 in Patients with Hypertensio
Phase 3
- Conditions
- Essential Hypertension
- Registration Number
- JPRN-jRCT2080221017
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Mild to moderate essential hypertension
Exclusion Criteria
1.History or symptom of sever cardiovascular complication(hear failure,stroke)
2.Hypertension caused by other disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diastolic blood pressure
- Secondary Outcome Measures
Name Time Method